Why 12 Compounds Outperform Single Peptides
Most longevity approaches focus on one compound at a time — NAD+ alone, Epitalon alone, BPC-157 alone. This is like treating a 12-system failure by fixing one system. The science is clear: aging is a multi-pathway process (12 hallmarks per Lopez-Otin 2023), and no single compound addresses more than 1-2 pathways.
Single Peptide vs Midas Protocol
| Approach | Pathways Addressed | Limitations |
|---|---|---|
| NAD+ alone | 1-2 (sirtuin, mitochondria) | Doesn't address senescence, telomeres, immune, collagen, repair |
| Epitalon alone | 1 (telomeres) | Doesn't address energy, inflammation, repair, GH |
| BPC-157 alone | 1 (tissue repair) | Doesn't address aging at cellular level |
| Midas Protocol (12) | 10 pathways | Comprehensive — addresses all major aging hallmarks |
Synergistic Interactions
Midas compounds amplify each other: NAD+ supports the sirtuins that help Epitalon maintain telomeres. FOXO4-DRI removes senescent cells that consume NAD+ via CD38. BPC-157 repairs tissue that TB-500 can then systemically support. CJC-1295 amplifies the GH pulse that Ipamorelin triggers. This is designed synergy, not random stacking.
Shop the Midas Longevity Protocol
12 compounds. 10 longevity pathways. 120 vials. ≥99% purity. Janoshik COA.
Buy at QSC →QSC Network
Shop QSC Compound Guides Ascension Stack Venus Protocol EU Warehouse